Chemosensory receptor ligand-based therapies
US9962344B2 · kind B2 · utility
11Cited by
24References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2016 |
| Grant date | May 8, 2018 |
| Priority date | — |
| Expiry date | Oct 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.